Prediction of Cardiovascular Events and Structural and Functional Remodeling of the Heart in Patients With Severe Mitral Regurgitation of Various Genesis Underwent Transcatheter Mitral Valve Repair “Edge-To-Edge”

Aim. To search for predictors of adverse cardiovascular events after edge-to-edge transcatheter mitral valve repair (TMVR) in patients with severe mitral regurgitation (MR) of various origins with an assessment of structural and functional remodeling of the heart and left ventricular (LV) contractile function.
Material and methods. The study included 73 patients (median age 71 [63; 80] years, 60.3% men) at a high surgical risk with severe MR of primary and secondary genesis, who underwent TMVR. The second-generation (58.9%) and fourth-generation (41.1%) clips were implanted. In addition to standard echocardiographic (EchoCG) indices, the parameters of left heart chamber longitudinal strain and LV myocardial function were assessed at baseline, on days 4-5, and at 6 and 12 months after the intervention. Also, the N-terminal fragment of the pro-brain natriuretic peptide (NT-proBNP) was assessed at baseline and on days 4-5 after TMVR.
Results. A significant decrease in MR was achieved during 12 months of follow-up. In the group with primary mitral regurgitation (PMR), MR decreased from 4.0 [3.4; 4.0] to 2.0 [1.5; 2.5] at one year of follow-up (p<0.001). In the group with secondary mitral regurgitation (SMR), MR decreased from 3.5 [3.0; 3.9] to 2.0 [2.0; 2.5] at 12 months of follow-up (p<0.001). This effect was associated with volumetric unloading of the left heart chambers evident as a significant decrease in the volumetric indices of the left chambers and an increase in the cardiac index. In the early postoperative period, the LV function was impaired as shown by decreases in the ejection fraction (EF), global longitudinal strain (GLS), LV myocardial function parameters, and an associated increase in NT-proBNP. By 12 months of follow-up, statistically significant improvements in global constructive work (GCW) and global work index (GWI) relative to baseline values were noted in both groups without significant changes in EF and LV GLS. A strong correlation was found between LV EF and GCW (r=0.812, p<0.001) and GWI (r=0.749, p<0.001). The overall survival was 89%, not differing between groups (p=0.72); the absence of hospitalization for decompensated heart failure (HF) was 79.5%, also without significant differences between the groups (p=0.78). According to multivariate regression analysis, the baseline GCW value was the strongest predictor of rehospitalization for decompensated HF (relative risk (RR) 0.997; 95% confidence interval (CI) 0.995-1.000; p=0.021) and the composite endpoint (CEP) (hospitalization for decompensated HF + all-cause mortality) (RR 0.998; 95% CI 0.996–1.000; p=0.033) in the cohort with PMR. In the group with SMR, the initial degree of MR was related with rehospitalization and the CEP (OR 12.252; 95% CI 2.125-70.651; p=0.005 and OR 16.098; 95% CI 2.944-88.044; p=0.001, respectively). The most significant predictor of overall mortality in the study population was the preoperative value of LV stroke volume (OR 0.824; 95% CI 0.750–0.906; p<0.001).
Conclusion. Edge-to-edge TMVR exerts a positive effect on the prognosis and structural and functional remodeling of the heart in patients with PMR and SMR. Myocardial function indices may be useful in assessing the LV contractile function in patients with severe MR of various origins. Identification of predictors for adverse cardiovascular events, including with new EchoCG technologies, may contribute to better patient stratification.

1. Bernard J, Altes A, Dupuis M, Toubal O, Mahjoub H, Tastet L et al. Cardiac Damage Staging Classification in Asymptomatic Moderate or Severe Primary Mitral Regurgitation. Structural Heart. 2022;6(1):100004. DOI: 10.1016/j.shj.2022.100004

2. Giustino G, Camaj A, Kapadia SR, Kar S, Abraham WT, Lindenfeld J et al. Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure. Journal of the American College of Cardiology. 2022;80(20):1857–68. DOI: 10.1016/j.jacc.2022.08.803

3. McCarthy PM, Whisenant B, Asgar AW, Ailawadi G, Hermiller J, Williams M et al. Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients With Primary Mitral Regurgitation Who Are Candidates for Surgery: Design and Rationale of the REPAIR MR Trial. Journal of the American Heart Association. 2023;12(4):e027504. DOI: 10.1161/JAHA.122.027504

4. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Revista Española de Cardiología (English Edition). 2022;75(6):524. DOI: 10.1016/j.rec.2022.05.006

5. Nyman CB, Mackensen GB, Jelacic S, Little SH, Smith TW, Mahmood F. Transcatheter Mitral Valve Repair Using the Edge-to-Edge Clip. Journal of the American Society of Echocardiography. 2018;31(4):434–53. DOI: 10.1016/j.echo.2018.01.012

6. Hausleiter J, Stocker TJ, Adamo M, Karam N, Swaans MJ, Praz F. Mitral valve transcatheter edge-to-edge repair. EuroIntervention. 2023;18(12):957–76. DOI: 10.4244/EIJ-D-22-00725

7. Rogers JH, Asch F, Sorajja P, Mahoney P, Price MJ, Maisano F et al. Expanding the Spectrum of TEER Suitability: Evidence From the EXPAND G4 Post Approval Study. JACC: Cardiovascular Interventions. 2023;16(12):1474–85. DOI: 10.1016/j.jcin.2023.05.014

8. Witkowski TG, Thomas JD, Debonnaire PJMR, Delgado V, Hoke U, Ewe SH et al. Global longitudinal strain predicts left ventricular dysfunction after mitral valve repair. European Heart Journal - Cardiovascular Ima ging. 2013;14(1):69–76. DOI: 10.1093/ehjci/jes155

9. Thomas JD, Kinno M. The Prognostic Role of Global Longitudinal Strain in Severe Primary Mitral Regurgitation: Moving Past the Proof-of-Concept Era. JACC: Cardiovascular Imaging. 2018;11(9):1245–7. DOI: 10.1016/j.jcmg.2018.04.011

10. Fukui M, Niikura H, Sorajja P, Hashimoto G, Bae R, Garcia S et al. Identification of Subclinical Myocardial Dysfunction and Association with Survival after Transcatheter Mitral Valve Repair. Journal of the American Society of Echocardiography. 2020;33(12):1474–80. DOI: 10.1016/j.echo.2020.07.003

11. Güvenç RÇ, Aruğaslan E, Güvenç TS, Karadeniz FÖ, Kaşıkçıoğlu H, Çam N. An Analysis of Myocardial Efficiency in Patients with Severe Asymptomatic Mitral Regurgitation. Journal of Cardiovascular Imaging. 2020;28(4):267–78. DOI: 10.4250/jcvi.2020.0038

12. Namazi F, Van Der Bijl P, Hirasawa K, Kamperidis V, Van Wijngaarden SE, Mertens B et al. Prognostic Value of Left Ventricular Global Longitudinal Strain in Patients With Secondary Mitral Regurgitation. Journal of the American College of Cardiology. 2020;75(7):750–8. DOI: 10.1016/j.jacc.2019.12.024

13. Papadopoulos K, Ikonomidis I, Chrissoheris M, Chalapas A, Kourkoveli P, Parissis J et al. MitraClip and left ventricular reverse remodelling: a strain imaging study. ESC Heart Failure. 2020;7(4):1409–18. DOI: 10.1002/ehf2.12750

14. Adamo M, Rubbio AP, Zaccone G, Pighi M, Massussi M, Tomasoni D et al. Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score. Euro-Intervention. 2023;18(17):1408–17. DOI: 10.4244/EIJ-D-22-00992

15. Raposeiras-Roubin S, Adamo M, Freixa X, Arzamendi D, Benito-González T, Montefusco A et al. A Score to Assess Mortality After Percutaneous Mitral Valve Repair. Journal of the American College of Cardiology. 2022;79(6):562–73. DOI: 10.1016/j.jacc.2021.11.041

16. Saidova M.A., Makeev M.I., Kuchin I.V., Komlev A.E., Imaev T.E., Akchurin R.S. Transcatheter edge-to-edge mitral valve repair in patients with severe mitral regurgitation. (The first Russian experience of one-year follow-up). Russian Cardiology Bulletin. 2023;18(4):33–40. DOI: 10.17116/Cardiobulletin20231804133

17. Bartko PE, Arfsten H, Heitzinger G, Pavo N, Toma A, Strunk G et al. A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation. Journal of the American College of Cardiology. 2019;73(20):2506–17. DOI: 10.1016/j.jacc.2019.02.075

18. Ahmed MI, Gladden JD, Litovsky SH, Lloyd SG, Gupta H, Inusah S et al. Increased Oxidative Stress and Cardiomyocyte Myofibrillar Degeneration in Patients With Chronic Isolated Mitral Regurgitation and Ejection Fraction >60%. Journal of the American College of Cardiology. 2010;55(7):671–9. DOI: 10.1016/j.jacc.2009.08.074

19. Constant Dit Beaufils A-L, Huttin O, Jobbe-Duval A, Senage T, Filippetti L, Piriou N et al. Replacement Myocardial Fibrosis in Patients With Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling, and Arrhythmia. Circulation. 2021;143(18):1763–74. DOI: 10.1161/CIRCULATIONAHA.120.050214

20. Neveu A, Aghezzaf S, Oger E, L’official G, Curtis E, Galli E et al. Primary mitral regurgitation: Toward a better quantification on left ventricular consequences. Clinical Cardiology. 2024;47(2):e24190. DOI: 10.1002/clc.24190

21. Cameli M, Lisi M, Giacomin E, Caputo M, Navarri R, Malandrino A et al. Chronic Mitral Regurgitation: Left Atrial Deformation Analysis by Two-Dimensional Speckle Tracking Echocardiography. Echocardiography. 2011;28(3):327–34. DOI: 10.1111/j.1540-8175.2010.01329.x

22. Cho EJ, Park S-J, Yun HR, Jeong DS, Lee S-C, Park SW et al. Predicting Left Ventricular Dysfunction after Surgery in Patients with Chronic Mitral Regurgitation: Assessment of Myocardial Deformation by 2-Dimensional Multilayer Speckle Tracking Echocardiography. Korean Circulation Journal. 2016;46(2):213–21. DOI: 10.4070/kcj.2016.46.2.213

23. Presume J, Lopes P, Freitas P, Albuquerque F, Reis C, Horta E et al. Secondary mitral regurgitation: Maintaining coherence with the American Society of Echocardiography grading guidelines, which proportionality concept best predicts prognosis in the real world? Revista Portuguesa de Cardiologia. 2022;41(12):1025–32. DOI: 10.1016/j.repc.2022.03.005

24. Adamo M, Godino C, Giannini C, Scotti A, Liga R, Curello S et al. Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry. European Journal of Heart Failure. 2019;21(2):196–204. DOI: 10.1002/ejhf.1343

25. Spieker M, Marpert J, Afzal S, Scheiber D, Bönner F, Horn P et al. Extent and determinants of left ventricular reverse remodeling in patients with secondary mitral regurgitation undergoing MitraClip implantation. IJC Heart & Vasculature. 2021;34:100804. DOI: 10.1016/j.ijcha.2021.100804

26. Suri RM, Schaff HV, Dearani JA, Sundt TM, Daly RC, Mullany CJ et al. Determinants of early decline in ejection fraction after surgical correction of mitral regurgitation. The Journal of Thoracic and Cardiovascular Surgery. 2008;136(2):442–7. DOI: 10.1016/j.jtcvs.2007.10.067

27. Pastore MC, Vannuccini F, Mandoli GE, Lisi M, Iuliano MA, Santoro A et al. Myocardial work and left heart deformation parameters across primary mitral regurgitation severity. International Journal of Cardiology. 2024;399:131772. DOI: 10.1016/j.ijcard.2024.131772

28. Ooms JF, Bouwmeester S, Debonnaire P, Nasser R, Voigt J-U, Schotborgh MA et al. Transcatheter Edge-to-Edge Repair in Proportionate Versus Disproportionate Functional Mitral Regurgitation. Journal of the American Society of Echocardiography. 2022;35(1):105-115.e8. DOI: 10.1016/j.echo.2021.08.002

29. Buccheri S, Capodanno D, Barbanti M, Popolo Rubbio A, Di Salvo ME, Scandura S et al. A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation. The American Journal of Cardiology. 2017;119(9):1443–9. DOI: 10.1016/j.amjcard.2017.01.024

30. Zweck E, Spieker M, Horn P, Iliadis C, Metze C, Kavsur R et al. Machine Learning Identifies Clinical Parameters to Predict Mortality in Patients Undergoing Transcatheter Mitral Valve Repair. JACC: Cardiovascular Interventions. 2021;14(18):2027–36. DOI: 10.1016/j.jcin.2021.06.039

31. De Sá Marchi MF, Van Den Dorpel M, Calomeni P, Chatterjee S, Adrichem R, Verhemel S et al. Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair. International Journal of Cardiology. 2024;400:131768. DOI: 10.1016/j.ijcard.2024.131768